CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors.
NCT07538635
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
High-risk R/R LBCL
Interventions
BIOLOGICAL:
Axicabtagene Ciloleucel
Sponsor
Zhejiang Cancer Hospital